4-Amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid ethyl ester (2) was prepared from 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-one (1) and ethyl bromoacetate. Compound 3 was synthesized by the condensation of 2 with hydrazine hydrate. The treatment of compound 3 with various aromatic aldehydes resulted in the formation of arylidene hydrazides as cistrans conformers 4a -g. Thiosemicarbazide derivative 5 was prepared by the reaction of compound 3 with phenylisothiocyanate. Cyclization of 5 with sodium hydroxide resulted in the formation of compound 6. Treatment of 6 with benzyl bromide gave compound 7. Four of the newly synthesized compounds were screened for their anticancer activity against a panel of 60 cell lines derived from nine cancer types, namely, non-small cell lung, colon, breast, ovarian, leukemia, renal, melanoma, prostate and CNS cancers at a fixed dose of 10 µ M.
Introduction
Cancer has always been among the most incurable diseases, and man has been prone to this deadly illness for ages. Even today, we lack the effective medicine or treatment that can be applied to most cancer sufferers. Thus, the quest for certain effective and less harmful cancer drugs is the priority of science [1] .
It was reported that compounds having triazole moieties, such as vorozole, letrozole and anastrozole appeared to be very effective aromatase inhibitors, which in turn prevented breast cancer [2 -4] . Some 1,2,4-triazole compounds are considered interesting heterocycles since they possess important pharmacological activities such as antifungal and antiviral activities. For example, fluconazole [5] , itraconazole [6] , ravuconazole [7] , ICI 153066 [8] , posaconazole [9] , and voriconazole [10] are antifungal drugs. Furthermore, certain 1,2,4-triazole derivatives have been reported as anticonvulsants [11] , antimicrobial [12] , antimalarial [13] , antihypertensive [14] , analgesic [15] , antiviral [16] , antiinflammatory [17] , antioxidant [18, 19] , antitumor [20, 21] , anti HIV [22] , fungicidal [23] , insecticidal [24] , herbicidal [25] , and pesticidal agents [26] . In addition to these, N-0932-0776 / 08 / 1100-1305 $ 06.00 c 2008 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com benzylidene derivatives of acid hydrazides are also associated with diverse biological activities [27, 28] . In an attempt to obtain new compounds with possible anticancer properties, some novel 1,2,4-triazole-5-one derivatives were designed and synthesized, and their anticancer properties were evaluated.
Results and Discussion Chemistry
The synthetic pathway leading to the title compounds is given in Scheme 1. The starting compound, 3-(4-methoxybenzyl)-4-amino-4,5-dihydro-1,2,4-triazole-5-one (1), was prepared according to the literature [29] . Treatment of 1 with ethyl bromoacetate in Na/absolute ethanol gave 1,2,4-triazol-1-yl-acetic acid ethyl ester 2. The IR spectrum of compound 2 showed absorption bands at 3291 and 3210 cm −1 corresponding to the NH 2 and at 1755 and 1709 cm −1 corresponding to ester C=O and triazole C=O groups, respectively. 1,2,4-Triazol-1-yl-acetic acid hydrazide 3 was prepared by the reaction of 2 and hydrazine hydrate in butanol.
Compound 3 was condensed with various aromatic aldehydes in ethanol to give the corresponding Schiff Scheme 1. Synthesis of the compounds.
bases 4a -g in very good yield. In the 1 H NMR spectra of compounds 4, NCH 2 , N=CH, and NH proton signals were recorded as double singlets, and in the 13 C NMR spectra of these compounds NCH 2 , triazole C-3, triazole C-5, and N=CH carbon signals were also recorded as double peaks. According to the literature, N-benzylidene derivatives of acid hydrazides may exist as E/Z geometrical isomers about C=N double bonds and cis/trans amide conformers (Scheme 2) [30 -33] . It is known that the N=CH double bond restricts rotation and gives rise to the formation of E and Z isomers with the E isomer dominating, and that the equilibration rate is rather low [30 -33] . It has been reported that when acid hydrazide derivatives are dissolved in polar solvents such as [D 6 ]DMSO, the geometrical E isomers of these compounds undergo a rapid cis/trans amide equilibrium, in which the trans conformer predominates [30 -33] . The E isomers and the cis/trans conformer ratios can easily be determined by 1 H NMR integration.
The chemical shift values of cis/trans conformers belonging to protons of NCH 2 , N=CH, OH, and NH in the 1 H NMR and to carbons of NCH 2 , triazole C-3, tri-azole C-5, and N=CH in the 13 C NMR spectra of compounds 4 and the percentage ratios of cis/trans conformers are given in Table 1 . These data prove the E isomers and trans conformer structures (I) to be dominant forms among the four possible structures [30 -33] . The proton signals of N=CH, NH, and OH of the trans conformer are found at higher field than those of the cis conformer. In contrast, the N-CH 2 proton signal of the trans conformer is found downfield compared to the cis conformer, because of steric hindrance [30] . The condensation of the acid hydrazide 3 with phenyl isothiocyanate resulted in the formation of thiosemicarbazide 5. The IR spectra of 5 exhibited a strong C=S absorption at 1246 cm −1 . The 13 C NMR signal of this group was observed at δ = 180.71 ppm. The 1 H NMR spectrum displayed three singlets due to three different -NH groups at δ = 9.61, 9.73 and 10.29 ppm. Cyclization of 5 with sodium hydroxide resulted in the formation of 1-(5-thioxo-1,2,4-triazol-3-yl)-5-oxo-4,5-dihydro-1,2,4-triazole 6. The IR spectrum of compound 6 showed a strong C=S absorption at 1358 cm −1 , and the 13 C NMR signal of this group was observed at δ = 168.14 ppm. The IR spectrum of 6 displayed bands at 3448 and 1358 cm −1 associated with the N-H and C=S functionalities. In the 1 H NMR spectrum of compound 6, the NH signal was observed as a singlet at δ = 13.90 ppm. Therefore, the compound was proven to be in the thionic form [34] . Treatment of 6 with benzyl bromide in Na/absolute ethanol gave the S-benzyl derivative 7. The 1 H NMR spectrum of compound 7 showed no signal belonging to an NH group. Instead, the S-CH 2 proton signals appeared at δ = 4.88 ppm as a singlet, and the S-CH 2 carbon signal at δ = 35.98 ppm.
Anticancer activity
The tumor growth inhibition properties of compounds 2, 3, 6, and 7 with the NCI codes NSC 741870, NSC 741871, NSC 741872, and NSC 741873, selected among compounds 1 -7 by the National Cancer Institute (NCI), USA, were screened on 60 human tumor cell lines, derived from nine cancer types, namely, non-small cell lung, colon, breast, ovarian, leukemia, renal, melanoma, prostate, and CNS cancers [35, 36] tivity on the whole cell panel, although they did not prove cytotoxic or cytostatic at the tested concentration (10 µ M). The screening data are presented in Table 2 . The performances of the four test compounds were evaluated individually on each cell type as well as all cell lines. The sensitivity orders of the cancer cell types to individual compounds were in the following orders The highest antiproliferative activity was observed against the CCRF-CEM leukemia cell line with average PG value of 15. Tumoricidal activity was observed only with compounds 3 and 6 against CCRF-CEM cell line with PG values of −13.82 and −66.63, respectively. Because all four compounds showed promising antitumor potential against the CCRF-CEM leukemia cell line among all cancer cell lines, and compounds 3 and 6 were even tumoricidal, synthesis and anticancer evaluation of structural analogs and various derivatives of these compounds deserve attention.
Conclusion
In conclusion, a series of 4-amino-3-(p-methoxybenzyl)-4,5-dihydro-1,2,4-triazole-5-one derivatives was synthesized as potential anticancer agents. Benzylidenehydrazide derivatives 4 appear as both configurational (E/Z) and conformational (cis/trans) isomers. The E geometrical isomers and trans amide conformers are dominant forms based on 1 H and 13 C NMR data. Compounds 2, 3, 6, and 7 were selected for a full 60-cell panel anticancer screening at a fixed dose of 10 µ M, where they showed mild activity. The highest activity was observed against leukemia cell types, with the lowest PG values. The leukemia subtype CCRF-CEM was the most susceptible to anticancer activity of the test compounds, and compounds 3 and 6 were even tumoricidal against this cell line with negative PG values. The synthesis of new analogs or derivatives of these compounds and testing of their anticancer activity especially against leukemia cancers should provide explanation in terms of structure -activity relationships and will probably yield better anticancer compounds.
Experimental Section

Chemistry
All chemicals used in this study were of high purity and purchased from Merck (Darmstadt, Germany) and Fluka (Buchs, Switzerland). Melting points were determined on a Büchi oil heated melting point apparatus (Büchi Labortechnik, Flawil, Switzerland) and are uncorrected. 1 [29] .
Synthesis of 4-amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid ethyl ester (2)
A mixture of 1 (0.01 mol) and Na (0.01 mol) was refluxed in absolute ethanol for 2 h. Then, ethyl bromoacetate (0.01 mol) was added and refluxed for an additional 6 h. After evaporating, the solid was recyrstallized from ethanolwater ( 
Synthesis of 4-amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid hydrazide (3)
A solution of 2 (0.01 mol) and hydrazine hydrate (0.01 mol) was refluxed in butanol for 4 h. The mixture was cooled, and the solid that separated was recrystallized from ethanol. M. p. 
General method for the synthesis of compounds 4
Compound 3 (0.01 mol) was refluxed with 0.01 mol of the appropriate aldehyde in ethanol for 4 h. The mixture was cooled, and the solid that separated was recrystallized from an appropriate solvent to afford the desired compound. 
4-Amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid 3-bromo-benzylidenehydrazide (4a)
M
4-Amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid 4-fluoro-benzylidenehydrazide (4b)
4-Amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid 4-(trifluoromethyl)-benzylidenehydrazide (4c)
4-Amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid 2,4-dichlorobenzylidenehydrazide (4d)
M. p. 270 -271 • C (DMSO-water
4-Amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid 5-bromo-2-hydroxybenzylidenehydrazide (4e)
4-Amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl-acetic acid 2-hydroxy-5-methoxybenzylidenehydrazide (4f)
Synthesis of 1-(4-amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl)-acetyl-4-phenyl thiosemicarbazide (5)
A mixture of 3 (0.01 mol) and phenyl isothiocyanate (0.01 mol) was refluxed in ethanol for 2 h. The mixture was cooled, and the solid that separated was recrystallized from ethanol. M. p. 
Synthesis of 1-(4-phenyl-5-thioxo-1,2,4-triazol-3-yl)methyl-4-amino-3-p-methoxybenzyl-5-oxo-4,5-dihydro-1,2,4-triazole (6)
Solid thiosemicarbazide 5 (0.01 mol) was added portionwise to 20 mL of a 2 N NaOH solution. The reaction mixture was refluxed for 2 h. The solution was cooled to r. t. and acidified to pH 3 -4 with 37 % HCl. The precipitated solid was filtered, washed thoroughly with water, dried, and recrystallized from ethanol-water (1 : 2 1-(4-phenyl-5-benzylthio-1,2,4-triazol-3-yl 
Synthesis of
Compound 6 (0.01 mol) was refluxed with an equivalent amount of sodium in absolute ethanol for 1 h. Then, benzyl bromide (0.01 mol) was added and the mixture refluxed for an additional 5 h. After evaporating, the solid was recyrstallized from ethanol-water (1 : 1 
Pharmacology
Sixty human cancer cell line anticancer screening
The human tumor cell lines of the cancer screening panel were grown in RPMI 1640 medium containing 5 % fetal bovine serum and 2 mM L-glutamine. Cells were inoculated into 96 well microtiter plates in 100 µ L samples at plating densities ranging from 5000 to 40000 cells/well depending on the doubling time of individual cell lines. After cell inoculation, the microtiter plates were incubated at 37 • C, 5 % CO 2 , 95 % air and 100 % relative humidity for 24 h prior to addition of the test compounds.
After 24 h, two plates of each cell line were fixed in situ with TCA, to represent a measurement of the cell population for each cell line at the time of compound addition (Tz). The compounds were solubilized in DMSO and diluted to 20 µ M, the complete medium containing 50 µg/mL gentamicin. Aliquots of 100 µL of the compound solution were added to the appropriate microtiter wells already containing 100 µL of medium, resulting in the required final compound concentration (10 µ M).
Following compound addition, the plates were incubated for an additional 48 h at 37 • C, 5 % CO 2 , 95 % air, and 100 % relative humidity. For adherent cells, the assay was terminated by the addition of cold TCA. Cells were fixed in situ by the gentle addition of 50 µL of cold 50 % (w/v) TCA (final concentration, 10 % TCA) and incubated for 60 min at 4 • C. The supernatant was discarded, and the plates were washed five times with tap water and air dried. Sulforhodamine B (SRB) solution (100 µL), 0.4 % (w/v) in 1 % acetic acid, was added to each well, and plates were incubated for 10 min at r. t. After staining, unbound dye was removed by washing five times with 1 % acetic acid, and the plates were air dried. Bound stain was subsequently solubilized with 10 mM trizma base, and the absorbance was read on an automated plate reader at a wavelength of 515 nm.
The measured effect of the compound on a cell line was calculated according to one or the other of the following two expressions and expressed as percent growth (PG):
If Mean OD test = The average of optical density measurement of SRB-derived color after 48 h exposure of cells to the test compound.
Mean OD ctrl = The average of optical density measurements of SRB-derived color after 48 h with no exposure of cells to the test compound.
Smaller positive PG values are indicative of better antiproliferative activity, and negative values show that the compound is tumoricidal, killing already existing cells.
